Bradykinin (1-5) (TFA)

Bradykinin (1-5) (TFA) is a major stable metabolite of Bradykinin (HY-P0206), formed by the proteolytic action of angiotensin-converting enzyme (ACE) . Bradykinin (1-5) (TFA) inhibits α- and γ-thrombin-induced platelet aggregation[1].

Product Specifications

UNSPSC

12352209

Target

Drug Metabolite

Related Pathways

Metabolic Enzyme/Protease

Field of Research

Cardiovascular Disease

Smiles

N=C(NCCC[C@@H](C(N1[C@@H](CCC1)C(N2[C@@H](CCC2)C(NCC(N[C@H](C(O)=O)CC3=CC=CC=C3)=O)=O)=O)=O)N)N.OC(C(F)(F)F)=O.[x]

Molecular Formula

C27H40N8O6.xHC2O2F3

Molecular Weight

572.66 (free base)

References & Citations

[1]Murphey LJ, et al. Bradykinin and its metabolite Bradykinin 1-5 inhibit thrombin-induced platelet aggregation in humans. J Pharmacol Exp Ther. 2006 Sep;318 (3) :1287-92.